Caribou Biosciences, Inc.
CRBU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $51 | $58 | $240 |
| Short-Term Investments | $193 | $278 | $189 | $135 |
| Receivables | $3 | $4 | $5 | $8 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $6 | $8 | $7 |
| Total Curr. Assets | $219 | $339 | $260 | $391 |
| Property Plant & Equip (Net) | $39 | $40 | $35 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $49 | $51 | $77 | $45 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $2 | $2 | $1 |
| Total NC Assets | $94 | $93 | $114 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $313 | $432 | $374 | $442 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $1 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $3 | $10 | $9 |
| Other Curr. Liab. | $24 | $21 | $16 | $13 |
| Total Curr. Liab. | $31 | $28 | $28 | $26 |
| LT Debt | $25 | $26 | $27 | $0 |
| Deferred Rev, NC | $3 | $6 | $16 | $22 |
| Deferred Tax Liab, NC | $1 | $1 | $0 | $0 |
| Other NC Liab. | $1 | $3 | $2 | $6 |
| Total NC Liab. | $30 | $36 | $45 | $29 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $26 | $27 | $28 | $0 |
| Total Liabilities | $60 | $64 | $73 | $55 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$448 | -$299 | -$197 | -$98 |
| AOCI | $0 | $0 | -$2 | -$0 |
| Other Equity | $701 | $668 | $500 | $486 |
| Total Equity | $253 | $368 | $301 | $388 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $313 | $432 | $374 | $442 |
| Net Debt | $10 | -$24 | -$31 | -$240 |